Effect of hyperprolinemia on acetylcholinesterase and butyrylcholinesterase activities in rat

Amino Acids

Volumn 28, Issue 3, 2005, Pages 305-308

  Delwing, D ^a   Chiarani, F ^a   Wannmacher, C M D ^a   Wajner, M ^a   Wyse, A T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Experimental model; Hyperprolinemia type II; Proline

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLINESTERASE; MELATONIN; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HYPERPROLINEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN CHEMISTRY; BUTYRYLCHOLINESTERASE; CEREBELLAR CORTEX; METABOLIC DISEASES; OXIDATIVE STRESS; PROLINE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 20044385594     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-005-0186-9     Document Type: Article

References (28)

1. Appleyard ME, Smith AD, Wilcock GK, Esiri MM (1983) Decreased CSF acetylcholinesterase activity in Alzheimer's disease. Lancet 2: 452
2. Benzi G, Moretti A (1998) Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease? Eur J Pharmacol 346: 1-13
3. Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res 21: 285-300
4. Cherkin A, Eckardt MJ, Gerbrandt LK (1976) Memory: proline induces retrograde amnesia in chicks. Science 193: 242-244
5. Chipperfield B, Newman PM, Moyes ICA (1981) Decreased erythrocyte cholinesterase activity in dementia. Lancet 2: 199
6. Delwing D, Chiarani F, Delwing D, Bavaresco CS, Wannmacher CMD, Wajner M, Wyse ATS (2003) Proline reduces acetylcholinesterase activity in cerebral cortex of rats. Metab Brain Dis 18: 79-86
7. Dubovy P, Haninec P (1990) Non-specific cholinesterase activity of the developing peripheral nerves and its possible function in cells in intimate contact with growing axons of chick embryo. Ont J Dev Neurosci 8: 589-602
8. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95
9. Giacobini E (2003) Cholinesterases: new roles in brain function and in Alzheimer's Disease. Neurochem Res 28: 515-522
10. Inestrosa NC, Perelman A (1990) Association of acetylcholinesterase with the cell surface. J Membr Biol 118: 1-9
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-267
12. Mack A, Robitzki A (2000) The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5′-butyrylcholinesterase - DNA study. Prog Neurobiol 60: 607-628
13. Melo JB, Agostinho P, Oliveira CR (2003) Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 45: 117-127
14. Mesulam M-M, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 170: 627-639
15. Moreira JCF, Wannmacher CMD, Costa SM, Wajner M (1989) Effect of proline administration on rat behavior in aversive and nonaversive tasks. Pharmacol Biochem Behav 32: 885-890
16. Nietfeld JJ, Kemp A (1981) The function of ascorbic with respect to propyl 4-hydroxylase activity. Biochim Biophys Acta 657: 159-167
17. O'Brien KK, Saxby BK, Ballard CG, Grace J, Harrington F, Ford GA, O'Brien JT, Swan AG, Fairbairn AF, Wesnes K, del Ser T, Edwardson JA, Morris CM, McKeith IG (2003) Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 13: 231-239
18. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457-1459
19. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56: 303-308
20. Phang JM, Hu CA, Valle D (2001) Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1821-1838
21. Saéz-Valero J, González-Garcia C, Ceña V (2003) Acetylcholinesterase activity and molecular isoform distribution are altered after focal cerebral ischemia. Mol Brain Res 117: 240-244
22. Silver A (1974) The biology of cholinesterases. American Elsevier Publishing, New York
23. Smith RC, Ho BT, Hsu L, Vroulis G, Claghorn J, Schoolar J (1982) Cholinesterase enzymes in the blood of patients with Alzheimer's disease. Life Sci 30: 543-546
24. Tajima S, Pinnell SR (1982) Regulation of collagen synthesis by ascorbic acid. Ascorbic acid increases type I procollagen mRNA. Biochem Biophys Res Commun 106: 632-637
25. Tsakiris S, Angelogianni P, Schulpis KH, Stavridis JC (2000) Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibiton induced by free radicals. Clin Biochem 33: 103-106
26. Wang LM, Han YF, Tang XC (2000) Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol 398: 65-72
27. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27: 1685-1689
28. 4 isoenzyme of acetylcholinesterase in patients with Alzheimer-type dementia and vascular dementia. Ann Clin Biochem 27: 321-326